Published March 7, 2018
| Version v1
Report
Open
A Multicenter, Double-blind, Randomized, Placebo-controlled, Double-dummy Trial of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients with Bipolar Depression
Description
This is a 8,027 page Clinical Study Report (CSR) for AstraZeneca trial 5077US/0049.
Notes
Thanks to James B. (Jim) Gottstein, Esq., President/CEO of the Law Project for Psychiatric Rights (http://psychrights.org), for making the file available.
Files
Study_049_CSR.pdf
Files
(54.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:46ca0bf4379a0d9234c353a4a11c1e36
|
54.6 MB | Preview Download |
Additional details
Related works
- Is cited by
- http://clinicaltrials.gov/show/NCT00214578 (URL)
- Is supplemented by
- 19358783 (PMID)
- References
- 10.1176/appi.ajp.162.7.1351 (DOI)